- AHSR Published Abstract “A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers” (October 2014)
- AT Forum article on CoOp model “OTPs Can Help Support Primary Care Buprenorphine Prescribers” (October 9, 2015)
- ATTC Messenger “Addressing the Prescription Opioid and Heroin Crisis” Authored By: Michael Botticelli – Director of National Drug Control Policy (September 2015)
- CoOP Model Example – Currently at Use at Johns Hopkins Medicine
- CoOp Poster – “Increasing Office-Based Buprenophine Availability and Efficacy through Coordination with Opioid Treatment Programs”
Authors: Kenneth Stoller, MD; Christopher Louie, MPH; Mary Ann Stephens, PhD - Dear Obot Physician Leader Letter
- Frequently Asked Questions
As supporters of #MedicationAssistedTreatment, we understand the dangers of allowing methadone – a Schedule II narcotic – to be distributed at local pharmacies.
ACT NOW by telling Congress to protect the #OTP standard of care & our communities: https://programnotapill.com/write-congress/ #PNAP
#aatod2022 conference
AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014
Contact Us
Phone : 212-566-5555
Email : info@aatod.org
Social Sharing
